144 related articles for article (PubMed ID: 7914182)
1. Endogenous tumor necrosis factor functions as a resistant factor against adriamycin.
Maeda M; Watanabe N; Okamoto T; Tsuji N; Niitsu Y
Int J Cancer; 1994 Aug; 58(3):376-9. PubMed ID: 7914182
[TBL] [Abstract][Full Text] [Related]
2. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity.
Tsuji Y; Watanabe N; Okamoto T; Tsuji N; Sasaki H; Akiyama S; Yamauchi N; Niitsu Y
Cancer Res; 1992 Nov; 52(22):6258-62. PubMed ID: 1423271
[TBL] [Abstract][Full Text] [Related]
3. Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells.
Watanabe N; Tsuji N; Tsuji Y; Sasaki H; Okamoto T; Akiyama S; Kobayashi D; Sato T; Yamauchi N; Niitsu Y
Pancreas; 1996 Nov; 13(4):395-400. PubMed ID: 8899800
[TBL] [Abstract][Full Text] [Related]
4. Induction of heat shock protein 72 synthesis by endogenous tumor necrosis factor via enhancement of the heat shock element-binding activity of heat shock factor 1.
Watanabe N; Tsuji N; Akiyama S; Sasaki H; Okamoto T; Kobayashi D; Sato T; Hagino T; Yamauchi N; Niitsu Y; Nakai A; Nagata K
Eur J Immunol; 1997 Nov; 27(11):2830-4. PubMed ID: 9394806
[TBL] [Abstract][Full Text] [Related]
5. Endogenous tumour necrosis factor regulates heat-inducible heat shock protein 72 synthesis.
Watanabe N; Tsuji N; Akiyama S; Sasaki H; Okamoto T; Kobayashi D; Sato T; Hagino T; Yamauchi N; Niitsu Y
Int J Hyperthermia; 1998; 14(3):309-17. PubMed ID: 9679710
[TBL] [Abstract][Full Text] [Related]
6. Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.
Okamoto T; Watanabe N; Yamauchi N; Tsuji Y; Tsuji N; Itoh Y; Neda H; Niitsu Y
Cancer Res; 1992 Oct; 52(19):5278-81. PubMed ID: 1327505
[TBL] [Abstract][Full Text] [Related]
7. Reversal of tumor necrosis factor resistance in tumor cells by adriamycin via suppression of intracellular resistance factors.
Watanabe N; Okamoto T; Tsuji N; Sasaki H; Akiyama S; Kobayashi D; Sato T; Yamauchi N; Niitsu Y
Jpn J Cancer Res; 1995 Apr; 86(4):395-9. PubMed ID: 7775261
[TBL] [Abstract][Full Text] [Related]
8. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
9. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients.
Kobayashi D; Watanabe N; Yamauchi N; Tsuji N; Sato T; Niitsu Y
Blood; 1997 Apr; 89(7):2472-9. PubMed ID: 9116291
[TBL] [Abstract][Full Text] [Related]
10. Induction of synthesis of manganous superoxide dismutase in L-M(pNTnF) cells carrying an inducible TNF gene.
Himeno T; Watanabe N; Yamauchi N; Maeda M; Okamoto T; Tsuji N; Tsuji Y; Akiyama S; Sasaki H; Niitsu Y
Int J Cancer; 1992 Feb; 50(3):458-62. PubMed ID: 1735614
[TBL] [Abstract][Full Text] [Related]
11. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity in pancreatic carcinoma cells via enhancement of the heart shock element-binding activity of heart shock factor 1.
Watanabe N; Tsuji N; Kobayashi D; Yamauchi N; Akiyama S; Sasaki H; Sato T; Okamoto T; Niitsu Y
Chemotherapy; 1997; 43(6):406-14. PubMed ID: 9395854
[TBL] [Abstract][Full Text] [Related]
12. Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients.
Watanabe N
Leuk Lymphoma; 1998 Aug; 30(5-6):477-82. PubMed ID: 9711910
[TBL] [Abstract][Full Text] [Related]
13. Suppression of intracellular resistance factors by adriamycin augments heat-induced apoptosis via interleukin-1beta-converting enzyme activation in pancreatic carcinoma cells.
Kobayashi D; Watanabe N; Sasaki H; Okamoto T; Tsuji N; Sato T; Yamauchi N; Niitsu Y
Int J Cancer; 1998 May; 76(4):552-5. PubMed ID: 9590133
[TBL] [Abstract][Full Text] [Related]
14. Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor.
Himeno T; Watanabe N; Yamauchi N; Maeda M; Tsuji Y; Okamoto T; Neda H; Niitsu Y
Cancer Res; 1990 Aug; 50(16):4941-5. PubMed ID: 2379159
[TBL] [Abstract][Full Text] [Related]
15. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C inhibitors augment tumor-necrosis-factor-induced apoptosis in normal human diploid cells.
Kobayashi D; Watanabe N; Yamauchi N; Tsuji N; Sato T; Sasaki H; Okamoto T; Niitsu Y
Chemotherapy; 1997; 43(6):415-23. PubMed ID: 9395855
[TBL] [Abstract][Full Text] [Related]
17. Induction of synthesis of heat shock protein 72 in tumor necrosis factor gene-transduced cells.
Watanabe N; Akiyama S; Tsuji N; Sasaki H; Yamauchi N; Okamoto T; Kobayashi D; Niitsu Y
Jpn J Cancer Res; 1994 Oct; 85(10):997-9. PubMed ID: 7961110
[TBL] [Abstract][Full Text] [Related]
18. Endogenous tumor necrosis factor promotes resistance to cellular stresses by inducing the metallothionein-1A gene.
Hadama T; Kinoshita M; Kobayashi D; Tsuji N; Watanabe N
Anticancer Res; 2002; 22(6C):4059-63. PubMed ID: 12553033
[TBL] [Abstract][Full Text] [Related]
19. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
20. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor.
Wong GH; Elwell JH; Oberley LW; Goeddel DV
Cell; 1989 Sep; 58(5):923-31. PubMed ID: 2476237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
